Abiraterone
The serum concentration of Tamsulosin can be increased when it is combined with Abiraterone.
Acebutolol
Acebutolol may increase the orthostatic hypotensive activities of Tamsulosin.
Adrafinil
Tamsulosin may decrease the vasoconstricting activities of Adrafinil.
Advertisement
Albuterol
Tamsulosin may decrease the vasoconstricting activities of Salbutamol.
Aldesleukin
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Aldesleukin.
Alfuzosin
Alfuzosin may increase the antihypertensive activities of Tamsulosin.
Advertisement
Aliskiren
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Aliskiren.
Alprenolol
Alprenolol may increase the orthostatic hypotensive activities of Tamsulosin.
Amifostine
The risk or severity of adverse effects can be increased when Amifostine is combined with Tamsulosin.
Advertisement
Amifostine Anhydrous
The risk or severity of adverse effects can be increased when Amifostine is combined with Tamsulosin.
Amiloride
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Amiloride.
Amiodarone
The serum concentration of Tamsulosin can be increased when it is combined with Amiodarone.
Amlodipine
The risk or severity of hypotension can be increased when Tamsulosin is combined with Amlodipine.
Amobarbital
Amobarbital may increase the hypotensive activities of Tamsulosin.
Amphotericin B
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Tamsulosin.
amphotericin B liposomal
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Tamsulosin.
Amyl Nitrite
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Amyl Nitrite.
Apalutamide
The serum concentration of Tamsulosin can be decreased when it is combined with Apalutamide.
Apomorphine
The risk or severity of adverse effects can be increased when Apomorphine is combined with Tamsulosin.
Apraclonidine
Tamsulosin may decrease the vasoconstricting activities of Apraclonidine.
Aprepitant
The serum concentration of Tamsulosin can be increased when it is combined with Aprepitant.
Arbutamine
Tamsulosin may decrease the vasoconstricting activities of Arbutamine.
Arformoterol
Tamsulosin may decrease the vasoconstricting activities of Arformoterol.
Aripiprazole
Aripiprazole may increase the hypotensive activities of Tamsulosin.
Arsenic Trioxide
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Tamsulosin.
Artemether
The metabolism of Tamsulosin can be decreased when combined with Artemether.
Atazanavir
The serum concentration of Tamsulosin can be increased when it is combined with Atazanavir.
Atenolol
Atenolol may increase the orthostatic hypotensive activities of Tamsulosin.
Atomoxetine
The metabolism of Tamsulosin can be decreased when combined with Atomoxetine.
Avanafil
Avanafil may increase the hypotensive activities of Tamsulosin.
Azilsartan
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Azilsartan medoxomil.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Azilsartan medoxomil.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Azilsartan medoxomil.
Barbexaclone
Barbexaclone may increase the hypotensive activities of Tamsulosin.
Barbital
Barbital may increase the hypotensive activities of Tamsulosin.
Benazepril
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Benazepril.
Bencyclane
The risk or severity of hypotension can be increased when Tamsulosin is combined with Bencyclane.
Bendroflumethiazide
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Bendroflumethiazide.
Bepridil
The risk or severity of hypotension can be increased when Tamsulosin is combined with Bepridil.
Betaxolol
Betaxolol may increase the orthostatic hypotensive activities of Tamsulosin.
Bisoprolol
Bisoprolol may increase the orthostatic hypotensive activities of Tamsulosin.
Bitolterol
Tamsulosin may decrease the vasoconstricting activities of Bitolterol.
Bitolterol Mesylate
Tamsulosin may decrease the vasoconstricting activities of Bitolterol.
Boceprevir
The serum concentration of Tamsulosin can be increased when it is combined with Boceprevir.
Bopindolol
Bopindolol may increase the orthostatic hypotensive activities of Tamsulosin.
Bortezomib
The metabolism of Tamsulosin can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Tamsulosin can be decreased when it is combined with Bosentan.
Bretylium
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Bretylium.
Brimonidine
Tamsulosin may decrease the vasoconstricting activities of Brimonidine.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Tamsulosin.
Bumetanide
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Bumetanide.
Bunazosin
Tamsulosin may increase the antihypertensive activities of Bunazosin.
Bupivacaine
The risk or severity of adverse effects can be increased when Bupivacaine is combined with Tamsulosin.
Bupranolol
Bupranolol may increase the orthostatic hypotensive activities of Tamsulosin.
Bupropion
The serum concentration of Tamsulosin can be increased when it is combined with Bupropion.
Canagliflozin
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Canagliflozin.
Canagliflozin Anhydrous
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Canagliflozin.
Candesartan Cilexetil
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Candesartan cilexetil.
Captopril
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Captopril.
Carbamazepine
The metabolism of Tamsulosin can be increased when combined with Carbamazepine.
Carteolol
Carteolol may increase the orthostatic hypotensive activities of Tamsulosin.
Carvedilol
Tamsulosin may increase the antihypertensive activities of Carvedilol.
Celecoxib
The metabolism of Tamsulosin can be decreased when combined with Celecoxib.
Celiprolol
Celiprolol may increase the orthostatic hypotensive activities of Tamsulosin.
Ceritinib
The serum concentration of Tamsulosin can be increased when it is combined with Ceritinib.
Chloroquine
The metabolism of Tamsulosin can be decreased when combined with Chloroquine.
Chlorothiazide
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Chlorothiazide.
Chlorpromazine
The metabolism of Tamsulosin can be decreased when combined with Chlorpromazine.
Chlorthalidone
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Chlorthalidone.
Cholecalciferol
The metabolism of Tamsulosin can be decreased when combined with Cholecalciferol.
Cilazapril
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Cilazapril.
Cimetidine
The serum concentration of Tamsulosin can be increased when it is combined with Cimetidine.
Cinacalcet
The serum concentration of Tamsulosin can be increased when it is combined with Cinacalcet.
Cinnarizine
The risk or severity of hypotension can be increased when Tamsulosin is combined with Cinnarizine.
Citalopram
The metabolism of Tamsulosin can be decreased when combined with Citalopram.
Clarithromycin
The serum concentration of Tamsulosin can be increased when it is combined with Clarithromycin.
Clemastine
The metabolism of Tamsulosin can be decreased when combined with Clemastine.
Clenbuterol
Tamsulosin may decrease the vasoconstricting activities of Clenbuterol.
Clevidipine
The risk or severity of hypotension can be increased when Tamsulosin is combined with Clevidipine.
Clevidipine butyrate
The risk or severity of hypotension can be increased when Tamsulosin is combined with Clevidipine.
Clobazam
The metabolism of Tamsulosin can be decreased when combined with Clobazam.
Clofarabine
The risk or severity of adverse effects can be increased when Clofarabine is combined with Tamsulosin.
Clomipramine
The metabolism of Tamsulosin can be decreased when combined with Clomipramine.
Clonidine
Tamsulosin may decrease the vasoconstricting activities of Clonidine.
Clotrimazole
The metabolism of Tamsulosin can be decreased when combined with Clotrimazole.
Clozapine
The metabolism of Tamsulosin can be decreased when combined with Clozapine.
Cobicistat
The serum concentration of Tamsulosin can be increased when it is combined with Cobicistat.
Cocaine
The serum concentration of Tamsulosin can be increased when it is combined with Cocaine.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Tamsulosin.
Crizotinib
The metabolism of Tamsulosin can be decreased when combined with Crizotinib.
Cyclandelate
The risk or severity of hypotension can be increased when Tamsulosin is combined with Cyclandelate.
Cyclosporine
The metabolism of Tamsulosin can be decreased when combined with Cyclosporine.
Dabrafenib
The serum concentration of Tamsulosin can be decreased when it is combined with Dabrafenib.
Dapagliflozin
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Dapagliflozin.
Darifenacin
The metabolism of Tamsulosin can be decreased when combined with Darifenacin.
Darunavir
The serum concentration of Tamsulosin can be increased when it is combined with Darunavir.
Dasatinib
The serum concentration of Tamsulosin can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Tamsulosin can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Tamsulosin can be decreased when it is combined with Deferasirox.
Delavirdine
The serum concentration of Tamsulosin can be increased when it is combined with Delavirdine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Tamsulosin.
Desipramine
The metabolism of Tamsulosin can be decreased when combined with Desipramine.
Dexmedetomidine
Tamsulosin may decrease the vasoconstricting activities of Dexmedetomidine.
Dichlorphenamide
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Diclofenamide.
Dihydroergotamine
The metabolism of Tamsulosin can be decreased when combined with Dihydroergotamine.
Diltiazem
The metabolism of Tamsulosin can be decreased when combined with Diltiazem.
Dinutuximab
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Dinutuximab.
Diphenhydramine
The metabolism of Tamsulosin can be decreased when combined with Diphenhydramine.
Dipivefrin
Tamsulosin may decrease the vasoconstricting activities of Dipivefrin.
Dipyridamole
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Dipyridamole.
Dobutamine
Tamsulosin may decrease the vasoconstricting activities of Dobutamine.
Dopexamine
Tamsulosin may decrease the vasoconstricting activities of Dopexamine.
Dothiepin
The serum concentration of Tamsulosin can be increased when it is combined with Dosulepin.
Doxazosin
Doxazosin may increase the antihypertensive activities of Tamsulosin.
Doxycycline
The metabolism of Tamsulosin can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Tamsulosin can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Tamsulosin can be decreased when combined with Dronedarone.
Droxidopa
Tamsulosin may decrease the vasoconstricting activities of Droxidopa.
Duloxetine
Tamsulosin may increase the orthostatic hypotensive activities of Duloxetine.
Eliglustat
The metabolism of Tamsulosin can be decreased when combined with Eliglustat.
Empagliflozin
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Empagliflozin.
Enalapril
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Enalapril.
Enalaprilat
The risk or severity of adverse effects can be increased when Enalaprilat is combined with Tamsulosin.
Enalaprilat Anhydrous
The risk or severity of adverse effects can be increased when Enalaprilat is combined with Tamsulosin.
Enzalutamide
The serum concentration of Tamsulosin can be decreased when it is combined with Enzalutamide.
Ephedrine
Tamsulosin may decrease the vasoconstricting activities of Ephedrine.
Epinastine
Tamsulosin may decrease the vasoconstricting activities of Epinastine.
Epinephrine
Tamsulosin may decrease the vasoconstricting activities of Epinephrine.
Eplerenone
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Eplerenone.
Epoprostenol
The risk or severity of adverse effects can be increased when Epoprostenol is combined with Tamsulosin.
Eprosartan
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Eprosartan.
Ergotamine
Tamsulosin may decrease the vasoconstricting activities of Ergotamine.
Erythromycin
The metabolism of Tamsulosin can be decreased when combined with Erythromycin.
Esmolol
Esmolol may increase the orthostatic hypotensive activities of Tamsulosin.
Ethacrynate
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Etacrynic acid.
Ethacrynic Acid
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Etacrynic acid.
Ethosuximide
The risk or severity of hypotension can be increased when Tamsulosin is combined with Ethosuximide.
Etilefrine
Tamsulosin may decrease the vasoconstricting activities of Etilefrine.
Felodipine
The risk or severity of hypotension can be increased when Tamsulosin is combined with Felodipine.
Fendiline
The risk or severity of hypotension can be increased when Tamsulosin is combined with Fendiline.
Fenoldopam
The risk or severity of adverse effects can be increased when Fenoldopam is combined with Tamsulosin.
Fenoterol
Tamsulosin may decrease the vasoconstricting activities of Fenoterol.
Fluconazole
The metabolism of Tamsulosin can be decreased when combined with Fluconazole.
Flunarizine
The risk or severity of hypotension can be increased when Tamsulosin is combined with Flunarizine.
Fluoxetine
The serum concentration of Tamsulosin can be increased when it is combined with Fluoxetine.
Fluspirilene
The risk or severity of hypotension can be increased when Tamsulosin is combined with Fluspirilene.
Fluvoxamine
The metabolism of Tamsulosin can be decreased when combined with Fluvoxamine.
Formoterol
Tamsulosin may decrease the vasoconstricting activities of Formoterol.
Fosamprenavir
The metabolism of Tamsulosin can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Tamsulosin can be increased when it is combined with Fosaprepitant.
Fosinopril
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Fosinopril.
Fosphenytoin
The metabolism of Tamsulosin can be increased when combined with Fosphenytoin.
Furosemide
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Furosemide.
Fusidate
The serum concentration of Tamsulosin can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Tamsulosin can be increased when it is combined with Fusidic Acid.
Gabapentin
The risk or severity of hypotension can be increased when Tamsulosin is combined with Gabapentin.
Gallopamil
The risk or severity of hypotension can be increased when Tamsulosin is combined with Gallopamil.
Guanabenz
Tamsulosin may decrease the vasoconstricting activities of Guanabenz.
Guanfacine
Tamsulosin may decrease the vasoconstricting activities of Guanfacine.
Haloperidol
The metabolism of Tamsulosin can be decreased when combined with Haloperidol.
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Tamsulosin.
Hexobarbital
Hexobarbital may increase the hypotensive activities of Tamsulosin.
Hexoprenaline
Tamsulosin may decrease the vasoconstricting activities of Hexoprenaline.
Hydralazine
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Hydralazine.
Hydrochlorothiazide
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Hydrochlorothiazide.
Hydroflumethiazide
The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Tamsulosin.
Hypoxis hemerocallidea root extract
The serum concentration of Tamsulosin can be decreased when it is combined with St. John's Wort.
Idelalisib
The serum concentration of Tamsulosin can be increased when it is combined with Idelalisib.
Iloprost
The risk or severity of adverse effects can be increased when Iloprost is combined with Tamsulosin.
Imatinib
The metabolism of Tamsulosin can be decreased when combined with Imatinib.
Imidapril
The risk or severity of adverse effects can be increased when Imidapril is combined with Tamsulosin.
Imipramine
The metabolism of Tamsulosin can be decreased when combined with Imipramine.
Inamrinone
The risk or severity of hypotension can be increased when Tamsulosin is combined with Amrinone.
Indapamide
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Indapamide.
Indinavir
The serum concentration of Tamsulosin can be increased when it is combined with Indinavir.
INDINAVIR ANHYDROUS
The serum concentration of Tamsulosin can be increased when it is combined with Indinavir.
Indoramin
Tamsulosin may increase the antihypertensive activities of Indoramin.
Irbesartan
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Irbesartan.
Isavuconazole
The serum concentration of Tamsulosin can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Tamsulosin can be decreased when combined with Isavuconazonium.
Isocarboxazid
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Tamsulosin.
Isoetharine
Tamsulosin may decrease the vasoconstricting activities of Isoetarine.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Tamsulosin.
Isoniazid
The metabolism of Tamsulosin can be decreased when combined with Isoniazid.
Isoproterenol
Tamsulosin may decrease the vasoconstricting activities of Isoprenaline.
Isosorbide Dinitrate
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Isosorbide Dinitrate.
Isosorbide Mononitrate
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Isosorbide Mononitrate.
Isoxsuprine
Tamsulosin may decrease the vasoconstricting activities of Isoxsuprine.
Isradipine
The metabolism of Tamsulosin can be decreased when combined with Isradipine.
Itraconazole
The serum concentration of Tamsulosin can be increased when it is combined with Itraconazole.
Ivacaftor
The serum concentration of Tamsulosin can be increased when it is combined with Ivacaftor.
Ketoconazole
The serum concentration of Tamsulosin can be increased when it is combined with Ketoconazole.
Labetalol
Labetalol may increase the antihypertensive activities of Tamsulosin.
Lacidipine
Tamsulosin may increase the hypotensive activities of Lacidipine.
Lamotrigine
The risk or severity of hypotension can be increased when Tamsulosin is combined with Lamotrigine.
Lercanidipine
The risk or severity of hypotension can be increased when Tamsulosin is combined with Lercanidipine.
Levetiracetam
The risk or severity of hypotension can be increased when Tamsulosin is combined with Levetiracetam.
Levobunolol
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Levobunolol.
Levobupivacaine
The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Tamsulosin.
Levodopa
Tamsulosin may increase the orthostatic hypotensive activities of Levodopa.
Levosimendan
The risk or severity of adverse effects can be increased when Levosimendan is combined with Tamsulosin.
Lisinopril
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Lisinopril.
Lisinopril Anhydrous
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Lisinopril.
Lofexidine
The risk or severity of adverse effects can be increased when Lofexidine is combined with Tamsulosin.
Loperamide
The risk or severity of hypotension can be increased when Tamsulosin is combined with Loperamide.
Lopinavir
The serum concentration of Tamsulosin can be increased when it is combined with Lopinavir.
Lorcaserin
The metabolism of Tamsulosin can be decreased when combined with Lorcaserin.
Losartan
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Losartan.
Lovastatin
The metabolism of Tamsulosin can be decreased when combined with Lovastatin.
Luliconazole
The serum concentration of Tamsulosin can be increased when it is combined with Luliconazole.
Lumacaftor
The metabolism of Tamsulosin can be increased when combined with Lumacaftor.
Lumefantrine
The metabolism of Tamsulosin can be decreased when combined with Lumefantrine.
Magnesium Sulfate
The risk or severity of hypotension can be increased when Tamsulosin is combined with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The risk or severity of hypotension can be increased when Tamsulosin is combined with Magnesium sulfate.
Manidipine
The risk or severity of hypotension can be increased when Tamsulosin is combined with Manidipine.
Mannitol
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Mannitol.
Mecamylamine
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Mecamylamine.
Mephentermine
Tamsulosin may decrease the vasoconstricting activities of Mephentermine.
Mephobarbital
Methylphenobarbital may increase the hypotensive activities of Tamsulosin.
Mepirodipine
The risk or severity of hypotension can be increased when Tamsulosin is combined with Barnidipine.
Metaproterenol
Tamsulosin may decrease the vasoconstricting activities of Orciprenaline.
Metaraminol
Tamsulosin may decrease the vasoconstricting activities of Metaraminol.
Methadone
The metabolism of Tamsulosin can be decreased when combined with Methadone.
Methazolamide
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Methazolamide.
Methohexital
Methohexital may increase the hypotensive activities of Tamsulosin.
Methotrimeprazine
The serum concentration of Tamsulosin can be increased when it is combined with Methotrimeprazine.
Methoxamine
Tamsulosin may decrease the vasoconstricting activities of Methoxamine.
Methsuximide
The risk or severity of hypotension can be increased when Tamsulosin is combined with Methsuximide.
Methyclothiazide
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Methyclothiazide.
Methyldopa
Tamsulosin may decrease the vasoconstricting activities of Methyldopa.
METHYLDOPA ANHYDROUS
Tamsulosin may decrease the vasoconstricting activities of Methyldopa.
Metipranolol
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Metipranolol.
Metolazone
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Metolazone.
Metoprolol
Metoprolol may increase the orthostatic hypotensive activities of Tamsulosin.
Mibefradil
The risk or severity of hypotension can be increased when Tamsulosin is combined with Mibefradil.
Midodrine
Tamsulosin may decrease the vasoconstricting activities of Midodrine.
Midostaurin
The serum concentration of Tamsulosin can be increased when it is combined with Midostaurin.
Mifepristone
The serum concentration of Tamsulosin can be increased when it is combined with Mifepristone.
Minoxidil
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Minoxidil.
Mirabegron
The metabolism of Tamsulosin can be decreased when combined with Mirabegron.
Mitotane
The serum concentration of Tamsulosin can be decreased when it is combined with Mitotane.
Moexipril
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Moexipril.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Tamsulosin.
Moxonidine
The risk or severity of adverse effects can be increased when Moxonidine is combined with Tamsulosin.
Nabilone
The risk or severity of adverse effects can be increased when Nabilone is combined with Tamsulosin.
Nadolol
Nadolol may increase the orthostatic hypotensive activities of Tamsulosin.
Naphazoline
Tamsulosin may decrease the vasoconstricting activities of Naphazoline.
Nebivolol
Nebivolol may increase the orthostatic hypotensive activities of Tamsulosin.
Nefazodone
The serum concentration of Tamsulosin can be increased when it is combined with Nefazodone.
Nelfinavir
The serum concentration of Tamsulosin can be increased when it is combined with Nelfinavir.
Nesiritide
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Nesiritide.
Netupitant
The serum concentration of Tamsulosin can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Tamsulosin can be increased when combined with Nevirapine.
Nicardipine
The metabolism of Tamsulosin can be decreased when combined with Nicardipine.
Nicorandil
Nicorandil may increase the hypotensive activities of Tamsulosin.
Nifedipine
The risk or severity of hypotension can be increased when Tamsulosin is combined with Nifedipine.
Nilotinib
The metabolism of Tamsulosin can be decreased when combined with Nilotinib.
Nilvadipine
The risk or severity of hypotension can be increased when Tamsulosin is combined with Nilvadipine.
Nimesulide
The risk or severity of hypotension can be increased when Tamsulosin is combined with Nimesulide.
Nimodipine
The risk or severity of hypotension can be increased when Tamsulosin is combined with Nimodipine.
Nisoldipine
The risk or severity of hypotension can be increased when Tamsulosin is combined with Nisoldipine.
Nitrendipine
The risk or severity of hypotension can be increased when Tamsulosin is combined with Nitrendipine.
Nitric Oxide
The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Tamsulosin.
Nitroglycerin
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Nitroglycerin.
Nitroprusside
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Nitroprusside.
Norepinephrine
Tamsulosin may decrease the vasoconstricting activities of Norepinephrine.
Nylidrin
Tamsulosin may decrease the vasoconstricting activities of Nylidrin.
Obinutuzumab
The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Tamsulosin.
Octylonium
The risk or severity of hypotension can be increased when Tamsulosin is combined with Otilonium.
Olaparib
The metabolism of Tamsulosin can be decreased when combined with Olaparib.
Olmesartan
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Olmesartan.
Olodaterol
Tamsulosin may decrease the vasoconstricting activities of Olodaterol.
Osimertinib
The serum concentration of Tamsulosin can be increased when it is combined with Osimertinib.
Oxprenolol
Oxprenolol may increase the orthostatic hypotensive activities of Tamsulosin.
Oxymetazoline
Tamsulosin may decrease the vasoconstricting activities of Oxymetazoline.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Tamsulosin.
Palbociclib
The serum concentration of Tamsulosin can be increased when it is combined with Palbociclib.
Panobinostat
The serum concentration of Tamsulosin can be increased when it is combined with Panobinostat.
Papaverine
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Papaverine.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Tamsulosin.
Paroxetine
The serum concentration of Tamsulosin can be increased when it is combined with Paroxetine.
Peginterferon Alfa-2b
The serum concentration of Tamsulosin can be decreased when it is combined with Peginterferon alfa-2b.
Penbutolol
Penbutolol may increase the orthostatic hypotensive activities of Tamsulosin.
Pentobarbital
The metabolism of Tamsulosin can be increased when combined with Pentobarbital.
Perindopril
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Perindopril.
Phenelzine
The risk or severity of adverse effects can be increased when Phenelzine is combined with Tamsulosin.
Phenobarbital
The metabolism of Tamsulosin can be increased when combined with Phenobarbital.
Phenoxybenzamine
The risk or severity of adverse effects can be increased when Phenoxybenzamine is combined with Tamsulosin.
Phentolamine
The risk or severity of adverse effects can be increased when Phentolamine is combined with Tamsulosin.
Phentolamine Mesylate
The risk or severity of adverse effects can be increased when Phentolamine is combined with Tamsulosin.
Phenylephrine
Tamsulosin may decrease the vasoconstricting activities of Phenylephrine.
Phenylpropanolamine
Tamsulosin may decrease the vasoconstricting activities of Phenylpropanolamine.
Phenytoin
The metabolism of Tamsulosin can be increased when combined with Phenytoin.
Pinaverium
The risk or severity of hypotension can be increased when Tamsulosin is combined with Pinaverium.
Pindolol
Pindolol may increase the orthostatic hypotensive activities of Tamsulosin.
Pipamperone
The risk or severity of adverse effects can be increased when Pipamperone is combined with Tamsulosin.
Pirbuterol
Tamsulosin may decrease the vasoconstricting activities of Pirbuterol.
Posaconazole
The serum concentration of Tamsulosin can be increased when it is combined with Posaconazole.
Practolol
Practolol may increase the orthostatic hypotensive activities of Tamsulosin.
Pramipexole
The risk or severity of adverse effects can be increased when Pramipexole is combined with Tamsulosin.
Prazosin
Prazosin may increase the antihypertensive activities of Tamsulosin.
Prenylamine
The risk or severity of hypotension can be increased when Tamsulosin is combined with Prenylamine.
Primidone
The metabolism of Tamsulosin can be increased when combined with Primidone.
Procaterol
Tamsulosin may decrease the vasoconstricting activities of Procaterol.
Promazine
The metabolism of Tamsulosin can be decreased when combined with Promazine.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Tamsulosin.
Propranolol
Propranolol may increase the orthostatic hypotensive activities of Tamsulosin.
Pseudoephedrine
Tamsulosin may decrease the vasoconstricting activities of Pseudoephedrine.
Quetiapine
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Quetiapine.
Quinapril
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Quinapril.
Quinidine
The serum concentration of Tamsulosin can be increased when it is combined with Quinidine.
Quinine
The metabolism of Tamsulosin can be decreased when combined with Quinine.
Racepinephrine
Tamsulosin may decrease the vasoconstricting activities of Racepinephrine.
Ramipril
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Ramipril.
Ranolazine
The metabolism of Tamsulosin can be decreased when combined with Ranolazine.
Rasagiline
The risk or severity of adverse effects can be increased when Rasagiline is combined with Tamsulosin.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Tamsulosin.
Reproterol
Tamsulosin may decrease the vasoconstricting activities of Reproterol.
Reserpine
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Reserpine.
Rifabutin
The metabolism of Tamsulosin can be increased when combined with Rifabutin.
Rifampin
The metabolism of Tamsulosin can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Tamsulosin can be increased when combined with Rifapentine.
Rilmenidine
Tamsulosin may decrease the vasoconstricting activities of Rilmenidine.
Riociguat
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Riociguat.
Risperidone
Tamsulosin may increase the hypotensive activities of Risperidone.
Ritodrine
Tamsulosin may decrease the vasoconstricting activities of Ritodrine.
Ritonavir
The serum concentration of Tamsulosin can be increased when it is combined with Ritonavir.
Rolapitant
The metabolism of Tamsulosin can be decreased when combined with Rolapitant.
Ropinirole
The metabolism of Tamsulosin can be decreased when combined with Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Ropivacaine is combined with Tamsulosin.
Rotigotine
The risk or severity of adverse effects can be increased when Rotigotine is combined with Tamsulosin.
Rucaparib
The metabolism of Tamsulosin can be decreased when combined with Rucaparib.
Sacubitril
The risk or severity of adverse effects can be increased when Sacubitril is combined with Tamsulosin.
Salmeterol
Tamsulosin may decrease the vasoconstricting activities of Salmeterol.
Saquinavir
The serum concentration of Tamsulosin can be increased when it is combined with Saquinavir.
Saquinavir Mesylate
The serum concentration of Tamsulosin can be increased when it is combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Tamsulosin can be decreased when used in combination with Sarilumab.
Secobarbital
Secobarbital may increase the hypotensive activities of Tamsulosin.
Selegiline
The risk or severity of adverse effects can be increased when Selegiline is combined with Tamsulosin.
Sertraline
The metabolism of Tamsulosin can be decreased when combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Tamsulosin.
Sildenafil
Sildenafil may increase the hypotensive activities of Tamsulosin.
Silodosin
Tamsulosin may increase the antihypertensive activities of Silodosin.
Siltuximab
The serum concentration of Tamsulosin can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Tamsulosin can be increased when it is combined with Simeprevir.
Sotalol
Sotalol may increase the orthostatic hypotensive activities of Tamsulosin.
Spironolactone
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Spironolactone.
ST. JOHN'S WORT EXTRACT
The serum concentration of Tamsulosin can be decreased when it is combined with St. John's Wort.
Streptokinase
The risk or severity of adverse effects can be increased when Streptokinase is combined with Tamsulosin.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Tamsulosin.
Sulfisoxazole
The metabolism of Tamsulosin can be decreased when combined with Sulfisoxazole.
Synephrine
Tamsulosin may decrease the vasoconstricting activities of Synephrine.
Tadalafil
Tadalafil may increase the hypotensive activities of Tamsulosin.
Talinolol
Talinolol may increase the orthostatic hypotensive activities of Tamsulosin.
Telaprevir
The serum concentration of Tamsulosin can be increased when it is combined with Telaprevir.
Telithromycin
The serum concentration of Tamsulosin can be increased when it is combined with Telithromycin.
Telmisartan
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Telmisartan.
Terazosin
Tamsulosin may increase the antihypertensive activities of Terazosin.
Terbinafine
The serum concentration of Tamsulosin can be increased when it is combined with Terbinafine.
Terbutaline
Tamsulosin may decrease the vasoconstricting activities of Terbutaline.
Terbutaline Sulfate
Tamsulosin may decrease the vasoconstricting activities of Terbutaline.
Thalidomide
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Thalidomide.
Thiamylal
Thiamylal may increase the hypotensive activities of Tamsulosin.
Thiopental
Thiopental may increase the hypotensive activities of Tamsulosin.
Thiopental Sodium
Thiopental may increase the hypotensive activities of Tamsulosin.
Thioridazine
The serum concentration of Tamsulosin can be increased when it is combined with Thioridazine.
Ticlopidine
The metabolism of Tamsulosin can be decreased when combined with Ticlopidine.
Timolol
Timolol may increase the orthostatic hypotensive activities of Tamsulosin.
Timolol Anhydrous
Timolol may increase the orthostatic hypotensive activities of Tamsulosin.
Tipranavir
The serum concentration of Tamsulosin can be increased when it is combined with Tipranavir.
Tizanidine
Tamsulosin may decrease the vasoconstricting activities of Tizanidine.
Tocilizumab
The serum concentration of Tamsulosin can be decreased when it is combined with Tocilizumab.
Tolazoline
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Tolazoline.
Tolcapone
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Tolcapone.
Tolfenamic Acid
The risk or severity of hypotension can be increased when Tamsulosin is combined with Tolfenamic Acid.
Torsemide
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Torasemide.
Trandolapril
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Trandolapril.
Tranilast
The risk or severity of hypotension can be increased when Tamsulosin is combined with Tranilast.
Tranylcypromine
The metabolism of Tamsulosin can be decreased when combined with Tranylcypromine.
Tretinoin
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Tretinoin.
Triamterene
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Triamterene.
Trimebutine
The risk or severity of hypotension can be increased when Tamsulosin is combined with Trimebutine.
Trimethadione
The risk or severity of hypotension can be increased when Tamsulosin is combined with Trimethadione.
Tulobuterol
Tamsulosin may decrease the vasoconstricting activities of Tulobuterol.
Urapidil
Tamsulosin may increase the antihypertensive activities of Urapidil.
Valsartan
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Valsartan.
Vardenafil
Vardenafil may increase the hypotensive activities of Tamsulosin.
Vemurafenib
The serum concentration of Tamsulosin can be decreased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Tamsulosin can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Tamsulosin can be decreased when combined with Verapamil.
Vinpocetine
The risk or severity of hypotension can be increased when Tamsulosin is combined with Vinpocetine.
Voriconazole
The serum concentration of Tamsulosin can be increased when it is combined with Voriconazole.
Xamoterol
Tamsulosin may decrease the vasoconstricting activities of Xamoterol.
Ziconotide
The risk or severity of hypotension can be increased when Tamsulosin is combined with Ziconotide.
Ziprasidone
The metabolism of Tamsulosin can be decreased when combined with Ziprasidone.
Zonisamide
The risk or severity of hypotension can be increased when Tamsulosin is combined with Zonisamide.
